These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20472841)

  • 1. Detection of vancomycin-intermediate Staphylococcus aureus with the updated Trek-Sensititre System and the MicroScan System. Comparison with results from the conventional Etest and CLSI standardized MIC methods.
    Nadarajah R; Post LR; Liu C; Miller SA; Sahm DF; Brooks GF
    Am J Clin Pathol; 2010 Jun; 133(6):844-8. PubMed ID: 20472841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
    Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
    Sader HS; Fritsche TR; Jones RN
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada.
    Webster D; Rennie RP; Brosnikoff CL; Chui L; Brown C
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):177-81. PubMed ID: 16938420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
    Bland CM; Porr WH; Davis KA; Mansell KB
    South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus.
    Swenson JM; Anderson KF; Lonsway DR; Thompson A; McAllister SK; Limbago BM; Carey RB; Tenover FC; Patel JB
    J Clin Microbiol; 2009 Jul; 47(7):2013-7. PubMed ID: 19420170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in vancomycin minimum inhibitory concentrations for Staphylococcus aureus obtained with the automated Phoenix™ system, the Clinical and Laboratory Standards Institute broth microdilution method and the standard Etest.
    Muñoz-Cobo B; Sancho-Tello S; Costa E; Bravo D; Torregrosa I; de Lomas JG; Navarro D
    Int J Antimicrob Agents; 2011 Mar; 37(3):278-9. PubMed ID: 21269809
    [No Abstract]   [Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
    J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Leonard SN; Rossi KL; Newton KL; Rybak MJ
    J Antimicrob Chemother; 2009 Mar; 63(3):489-92. PubMed ID: 19136530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
    Sader HS; Becker HK; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies.
    Keel RA; Sutherland CA; Aslanzadeh J; Nicolau DP; Kuti JL
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):326-9. PubMed ID: 20955917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur?
    Kleinschmidt SL; Munckhof WJ; Nimmo GR
    Int J Antimicrob Agents; 2006 Feb; 27(2):168-70. PubMed ID: 16420976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.
    Kosowska-Shick K; Ednie LM; McGhee P; Smith K; Todd CD; Wehler A; Appelbaum PC
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4510-3. PubMed ID: 18838583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
    Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.
    Alós JI; García-Cañas A; García-Hierro P; Rodríguez-Salvanés F
    J Antimicrob Chemother; 2008 Oct; 62(4):773-5. PubMed ID: 18552338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.
    Fridkin SK; Hageman J; McDougal LK; Mohammed J; Jarvis WR; Perl TM; Tenover FC;
    Clin Infect Dis; 2003 Feb; 36(4):429-39. PubMed ID: 12567300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates.
    Hussain FM; Boyle-Vavra S; Shete PB; Daum RS
    J Infect Dis; 2002 Sep; 186(5):661-7. PubMed ID: 12195353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of increase in vancomycin resistance of pediatric methicillin-resistant Staphylococcus aureus Isolates from 2000 to 2007.
    Zheng X; Qi C; Arrieta M; O'Leary A; Wang D; Shulman ST
    Pediatr Infect Dis J; 2010 Sep; 29(9):882-4. PubMed ID: 20453708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.